Sodium Chloride Injection Recalled By Hospira Over Particulate Risk

Posted on

In a news release on the website of the Food and Drug Administration, Hospira explains a recall they issued way back in August.  At that time, the company recalled one lot of .9% Sodium Chloride Injection, USP, 100 mL, Flexible Container.  Customers should have heard about the problem last year, but those who still have the product in their possession are being advised to quarantine it at once and then call Stericycle for further recall instructions.  The product, which is meant to provide a patient with electrolytes and water, was recalled after an individual reportedly found particulates in four separate units of the item.  Such particulates could lead to things like inflammation, allergic responses, or phlebitis, although thankfully, no such instances have been reported at this time.

For more about the recall, follow this link.